Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy

Publisher： Karger

E-ISSN： 1421-9662|126|3|147-150

ISSN： 0001-5792

Source： Acta Haematologica, Vol.126, Iss.3, 2011-07, pp. : 147-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Interleukin-6 Receptor Antibody Treatment in Inflammatory Autoimmune Diseases

By  

Reviews on Recent Clinical Trials, Vol. 1, Iss. 3, 2006-09 ,pp. : 193-200

Bentham Science Publishers

Access to resources Recommend Favorite

Plasmablastic microlymphoma arising in human herpesvirus‐8‐associated multicentric Castleman disease in a human immunodeficiency virus‐seronegative patient with clinical response to anti‐interleukin‐6 therapy

By  

HISTOPATHOLOGY, Vol. 67, Iss. 6, 2015-12 ,pp. : 930-932

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases

By Alten Rieke   Maleitzke Tazio  

Annals of Medicine, Vol. 45, Iss. 4, 2013-06 ,pp. : 357-363

Informa Healthcare

Access to resources Recommend Favorite

Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 3, 2015-03 ,pp. : 204-207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti‐Interleukin Therapy in Asthma

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 1, 2015-01 ,pp. : 55-65

John Wiley & Sons Inc

Access to resources Recommend Favorite